Obesity and bone health: reconciling the density–fragility paradox

• by Riad Sulimani

• July 10, 2026

Interplay between MASLD, obesity and type 2 diabetes: epidemiology, shared pathways and clinical implications

• by Kenneth Tachi, Adwoa Agyei-Nkansah, Yacoba Atiase, Bright Forkuo, Victoria Akosua Agyen-Frimpong

• July 2, 2026

ACP Ranks Obesity Drug Options

A living clinical guideline outlines a treatment hierarchy for selected pharmacologic therapies in patients with obesity and selected patients with overweight.

• by Kathryn Wighton

• July 6, 2026

• 4 min

The gut microbiota as a potential determinant of response to GLP-1 receptor agonists: a narrative review

• by Luigi Regenburgh De La Motte, Francesca Carreras, Lorenzo Drago

• July 6, 2026